- Home
- JTAI vs POAI Comparison
JTAI vs POAI Comparison
Compare JTAI & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JTAI
- POAI
- Stock Information
- Founded
- JTAI 2018
- POAI 2002
- Country
- JTAI United States
- POAI United States
- Employees
- JTAI N/A
- POAI N/A
- Industry
- JTAI Blank Checks
- POAI Industrial Specialties
- Sector
- JTAI Finance
- POAI Health Care
- Exchange
- JTAI Nasdaq
- POAI Nasdaq
- Market Cap
- JTAI 8.3M
- POAI 7.8M
- IPO Year
- JTAI N/A
- POAI N/A
- Fundamental
- Price
- JTAI $3.19
- POAI $0.95
- Analyst Decision
- JTAI Strong Buy
- POAI Hold
- Analyst Count
- JTAI 1
- POAI 1
- Target Price
- JTAI $11.00
- POAI N/A
- AVG Volume (30 Days)
- JTAI 40.5K
- POAI 124.3K
- Earning Date
- JTAI 08-15-2025
- POAI 11-11-2025
- Dividend Yield
- JTAI N/A
- POAI N/A
- EPS Growth
- JTAI N/A
- POAI N/A
- EPS
- JTAI N/A
- POAI N/A
- Revenue
- JTAI $12,790,684.00
- POAI $1,664,696.00
- Revenue This Year
- JTAI $13.37
- POAI $486.27
- Revenue Next Year
- JTAI $201.13
- POAI $65.50
- P/E Ratio
- JTAI N/A
- POAI N/A
- Revenue Growth
- JTAI N/A
- POAI 71.65
- 52 Week Low
- JTAI $2.30
- POAI $0.55
- 52 Week High
- JTAI $57.17
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- JTAI 46.25
- POAI 58.00
- Support Level
- JTAI $3.09
- POAI $0.90
- Resistance Level
- JTAI $3.26
- POAI $1.08
- Average True Range (ATR)
- JTAI 0.14
- POAI 0.07
- MACD
- JTAI 0.00
- POAI 0.00
- Stochastic Oscillator
- JTAI 30.95
- POAI 43.48
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.